MedPath
NMPA Approval

Salbutamol Sulfate Inhalation Solution

国药准字H20244093

June 18, 2024

Drug Information

吸入用硫酸沙丁胺醇溶液

吸入制剂

2.5ml:5mg(按C₁₃H₂₁NO₃计)

化学药品

June 18, 2024

Company Information

Applicant Company

南京市江北新区星晖路 71 号加速器六期厂房9栋

Manufacturing Company

南京市江北新区华康路122号加速器四期01栋

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

吸入用硫酸沙丁胺醇溶液 - NMPA 批准文号 | MedPath